La catena delle opzioni mostra i dati chiave delle opzioni azionarie di  a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per ..

 (NYSE:AGS) Azioni, Catena delle Opzioni

PlayAGS

Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) shares edged slightly higher in early Wednesday trading as the aerospace firm marked <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/n46217980/boeing-delivers-next-generation-o3b-mpower-satellites-to-ses" rel="noreferrer noopener">another step in its satellite rollout.</a>
The company recently completed the delivery of its ninth and tenth O3b mPOWER satellites, continuing its partnership with network operator SES to enhance space-based internet access.
Amid this progress, however, Boeing found itself under renewed scrutiny following an unrelated midair incident involving one of its commercial aircraft.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/25/07/46190114/boeing-spirit-deal-under-scrutiny-of-british-competition-authorities-as-initial-probe-begins-report" rel="noreferrer noopener">UK Antitrust Probe Targets Boeing&#8217;s Spirit Deal As Airbus Sells Off Assets</a>
A Japan Airlines Co. flight operated by Spring Airlines Japan was forced to make an emergency landing after its Boeing 737-800 experienced a <a target="_blank" href="https://www.benzinga.com/markets/equities/25/07/46214283/boeing-737s-violent-26000-foot-plunge-left-passengers-legs-shaking-as-japan-airlines-flight-makes-emergency-landing-191-survive-midair-pressure" rel="noreferrer noopener">pressurization system failure</a>.
Flight JL8696, en route from Shanghai to Tokyo, rapidly descended from 32,800 feet and diverted to Osaka&#8217;s Kansai Airport around 8:50 p.m. local time on Monday.
All 191 passengers and crew escaped without injury, according to Japanese officials.
Meanwhile, the newly delivered O3b mPOWER satellites are en route to Kennedy Space Center in Florida, with launch preparations set for this summer. The spacecraft feature adaptive software-defined payloads capable of reallocating power dynamically to meet changing connectivity demands.
Michelle Parker, vice president of Boeing Space Mission Systems, called the satellites the most advanced of their kind. "Our software-defined payload technology allows SES to deliver high-speed, reliable connectivity, adapting in real-time to user demand," Parker said, referencing common issues with inconsistent internet on aircraft and ships.
Now in its second generation, SES's O3b mPOWER constellation operates in medium Earth orbit—about 8,000 kilometers above Earth—delivering faster, lower-latency service for sectors reliant on continuous global connectivity.
With ten satellites already in orbit and three more in production, SES aims to further evolve its broadband infrastructure.
Boeing is also repurposing this advanced payload technology for defense use, adapting it for the Wideband Global SATCOM (WGS) 11 and 12 satellites under development for the United States Space Force.
These upgraded systems are built to deliver resilient, secure communications even in contested environments.
As a leader across commercial and defense aerospace, Boeing continues to serve clients in over 150 countries, anchored by a global supply chain and a commitment to safety, quality, and technological innovation.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, BA stock has gained over 13% in the past year. Investors can gain exposure to the stock via&nbsp;Direxion Daily BA Bull 2X Shares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOEU#NASDAQ">BOEU</a>).
Price Action: BA shares are trading higher by 0.43% to $210.58 at last check on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46218060/hut-8s-ontario-power-plants-secure-long-term-contracts-stock-soars" target="_blank" rel="noreferrer noopener">Hut 8&#8217;s Ontario Power Plants Secure Long-Term Contracts, Stock Soars</a></li>
</ul>
Photo: Shutterstock

Equities

News

Markets

Movers

General

BOEU

What's Going On With Boeing Stock Today?

Canaccord Genuity analyst Maria Ripps maintains Life360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIF#NASDAQ">LIF</a>) with a Buy and raises the price target from $70 to $75.

Price Target

Analyst Ratings

Canaccord Genuity Maintains Buy on Life360, Raises Price Target to $75

Canaccord Genuity analyst Sumant Kulkarni maintains ATAI Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATAI#NASDAQ">ATAI</a>) with a Buy and raises the price target from $11 to $12.

ATAI

Canaccord Genuity Maintains Buy on ATAI Life Sciences, Raises Price Target to $12

Anthropic is officially speeding in the revenue fast lane. The <a href="https://www.benzinga.com/topic/artificial-intelligence" target="_blank" rel="noopener">generative AI startup</a>, best known for its Claude models, has reportedly hit a $4 billion annualized revenue run rate, just months after being pegged at around $1 billion in late 2024. That's not just acceleration &#8211; it's warp speed.
The jump, first <a href="https://www.theinformation.com/articles/anthropic-revenue-hits-4-billion-annual-pace-competition-cursor-intensifies?offer=rtsu-engagement-25%2Crtsu-featured-articles-pro&amp;utm_campaign=RTSU%3A+Anthropic+Reve&amp;utm_content=9168&amp;utm_medium=email&amp;utm_source=cio&amp;utm_term=6133">reported</a> by The Information, places Anthropic in an elite tier of AI-first companies monetizing at scale. Driven by enterprise demand and token-based API usage, Claude has gone from up-and-comer to high earner in under a year. It's a remarkable rise for a firm that made just $10 million in 2022.
Read Also: <a href="https://www.benzinga.com/markets/tech/25/07/46217817/palantirs-tech-to-supercharge-us-navy-shipbuilding">Palantir&#8217;s Tech To Supercharge US Navy Shipbuilding</a>
Meanwhile, Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) &#8211; the OG of enterprise AI &#8211; finds itself in the unfamiliar position of trailing the new kid on the block. Palantir ended 2024 with $2.87 billion in revenue and is <a href="https://investors.palantir.com/news-details/2025/Palantir-Reports-Q1-2025-Revenue-Growth-of-39-YY-U-S--Revenue-Growth-of-55-YY-Raises-FY-2025-Revenue-Guidance-to-36-YY-Growth-and-U-S--Comm-Revenue-Guidance-to-68-YY-Crushing-Consensus-Expectations/#:~:text=For%20full%20year%202025%3A,rate%20of%20at%20least%2068%25.">guiding</a> for around $3.9 billion in 2025. Close, but not quite at the $4 billion milestone.
For investors, the contrast is striking. Palantir's business is steady, rooted in defense contracts and a growing roster of commercial clients adopting its AIP (Artificial Intelligence Platform). But its growth curve, while respectable, isn't grabbing headlines like Anthropic's explosive scaling.
<h2 class="wp-block-heading">Is Anthropic The New Palantir?</h2>
So, is Anthropic the new Palantir &#8211; or something else entirely? While Palantir still dominates in government AI, Anthropic's model-driven approach is clearly resonating with the enterprise crowd. It's a reminder that the AI arms race isn't just about GPU access &#8211; it's about who can turn hype into high-margin, recurring revenue.
As Anthropic charges past the $4 billion annual clip and Palantir inches closer, the real question is: who reaches $10 billion first?
One thing's clear: in the monetization race, Claude just dropped the hammer &#8211; and Palantir will need more than Gotham and AIP to catch up.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46180484/nvidia-palantir-tech-stocks-to-buy-q3-2025-sectors">Nvidia, Palantir Fuel Historic Tech Rally — And It&#8217;s Far From Done</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Tech

Trading Ideas

PLTR

Palantir's No Longer The Benchmark - Anthropic Just Took The Lead

Truist Securities analyst Jasper Bibb upgrades ABM Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) from Hold to Buy and raises the price target from $55 to $58.

Upgrades

Truist Securities Upgrades ABM Indus to Buy, Raises Price Target to $58

Tigress Financial analyst Ivan Feinseth maintains Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) with a Buy and raises the price target from $115 to $120.

Tigress Financial Maintains Buy on Walmart, Raises Price Target to $120

WIIM

ENVX

Enovix shares are trading higher after the company announced a $60 million share repurchase program.

Morgan Stanley analyst Michael Cyprys maintains WisdomTree (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>) with a Equal-Weight and raises the price target from $9.75 to $11.

Morgan Stanley Maintains Equal-Weight on WisdomTree, Raises Price Target to $11

Barrington Research analyst Vincent Colicchio maintains Asure Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASUR#NASDAQ">ASUR</a>) with a Outperform and maintains $17 price target.

ASUR

Barrington Research Maintains Outperform on Asure Software, Maintains $17 Price Target

Data show confirmed ORR of 83% (10/12) at doses selected for ongoing expansion study
Median follow-up of 9.0 months as of the updated data cutoff
Responses observed in patients with low PD-L1 and/or CLDN18.2 expression
Company to host investor event on Tuesday, July 8th
ROCKVILLE, Md., July 02, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMAB#NASDAQ">IMAB</a>) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced the presentation of positive Phase 1b combination data for givastomig, in combination with nivolumab and mFOLFOX6, at the European Society for Medical Oncology Gastrointestinal Cancers Congress 2025 (ESMO GI 2025) in Barcelona (abstract #388MO). Givastomig is a bispecific antibody targeting Claudin 18.2 and 4-1BB. I-Mab plans to host a virtual investor event on Tuesday, July 8th (register <a href="https://www.globenewswire.com/Tracker?data=1LmMD9viZ6iOkYKopeaqjzYBs1vFGdhayyfXtV3W9a-7iZIrR8MsY1dcwgYokxt8X5QJrqtfXF1YX2-GXng0F_jSogkEYNdJYD0qcbemr0g=">here</a>) to review these data.
The Phase 1b data (NCT04900818) show a confirmed objective response rate (ORR) of 71% across all doses (12/17), and 83% (10/12) at doses selected for the ongoing dose expansion study (8 mg/kg and 12 mg/kg). Responses occurred in tumors with low levels of PD-L1 expression and/or Claudin 18.2 (CLDN18.2) expression, with favorable overall tolerability. There were no Grade 3 or greater events for nausea and vomiting, and only one Grade 3 TRAE for increased liver enzymes. The data are based on the results of the dose escalation part of a Phase 1b study evaluating the givastomig combination as first line therapy (1L) in patients with Claudin 18.2-positive gastric cancers (≥1+ IHC staining intensity in ≥1% of tumor cells). The primary endpoint is safety. The study enrolled only patients in the U.S.

IMAB

I-Mab Presents Phase 1b Combination Data For Givastomig, In Combination With Nivolumab And mFOLFOX6, At ESMO GI 2025 In Barcelona

Corteva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) has outperformed the market over the past 5 years by 8.41% on an annualized basis producing an average annual return of 22.96%. Currently, Corteva has a market capitalization of $51.24 billion. 
Buying $100 In CTVA: If an investor had bought $100 of CTVA stock 5 years ago, it would be worth $277.12 today based on a price of $75.11 for CTVA at the time of writing.
<h3>Corteva's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751469392_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTVA

Here's How Much $100 Invested In Corteva 5 Years Ago Would Be Worth Today

Morgan Stanley analyst Simeon Gutman maintains Wayfair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) with a Overweight and raises the price target from $50 to $70.

Morgan Stanley Maintains Overweight on Wayfair, Raises Price Target to $70

Kilroy Realty Corp's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRC#NYSE">KRC</a>) near-term performance is likely to be impacted by a <a href="https://www.benzinga.com/money/what-is-a-cap-rate-in-real-estate">decline in capitalized interest</a>, according to JPMorgan.
The Kilroy Realty Analyst: Analyst Anthony Paolone maintained an Overweight rating, while cutting the price target from $42 to $40.
The Kilroy Realty Thesis: The company has been indicating less capitalized interest in 2026 for a couple quarters, Paolone said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Kilroy Oyster Point – Phase 2 (KOP II), which is Kilroy Realty&#8217;s $1.025 billion life science development in San Francisco, is currently "0% leased," he stated.
If the Street lowers estimates, it should not come as much of a surprise "since the key drags are so well known," the analyst said.
The bigger picture remains the same, including expectations of "office leasing in San Francisco, the Silicon Valley, and Seattle recovering with more tenant traffic and leases being signed in the market," he further wrote.
Price Action: Shares of Kilroy Realty had declined by 0.03% to $34.55 at the time of publication on Wednesday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/04/44613610/kilroy-realty-to-gain-from-high-quality-assets-analyst-says-stock-appears-cheap-from-real-estate-valuation-perspective">Kilroy Realty Appears Cheap From Real Estate Valuation Perspective: Analyst</a></li>
</ul>
Image: Shutterstock

Analyst Color

Reiteration

This Kilroy Realty Analyst Cuts Price Target On Lower Capitalized Interest, Delayed Leasing

DFDV

DeFi Development shares are trading lower after the company announced plans for a $100 million convertible notes offering.

Morgan Stanley analyst Michael Cyprys maintains Virtus Inv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRTS#NYSE">VRTS</a>) with a Underweight and raises the price target from $152 to $171.

VRTS

Morgan Stanley Maintains Underweight on Virtus Inv, Raises Price Target to $171

Morgan Stanley analyst Michael Cyprys maintains T. Rowe Price Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROW#NASDAQ">TROW</a>) with a Equal-Weight and raises the price target from $95 to $104.

TROW

Morgan Stanley Maintains Equal-Weight on T. Rowe Price Group, Raises Price Target to $104

<a href="https://x.com/senwarren/status/1940424688750211182?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg" title="https://x.com/senwarren/status/1940424688750211182?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg">https://x.com/senwarren/status/1940424688750211182?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg</a>

Legal

PARA

PARAA

Elizabeth Warren Posts On X "This looks like bribery in plain sight. Paramount folded at the same time it needs Trump's approval for a billion-dollar merger. I'm calling for an investigation into whether any anti-bribery laws were broken, and I'm working on a new bill to rein in this kind of corruption."

Rivian Automotive Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) released its second-quarter 2025 <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/b46217973/rivian-releases-q2-2025-production-and-delivery-figures-announces-funding-of-1b-volkswagen-group-i" rel="noreferrer noopener">production and delivery results</a> on Wednesday, reflecting its continued focus on transitioning to next-generation electric vehicle models.
The company produced 5,979 vehicles between April and June and delivered 10,661 units from its Normal, Illinois, plant. Despite a planned reduction in output to prepare for its 2026 lineup, Rivian reaffirmed its full-year delivery guidance of 40,000 to 46,000 vehicles.
It also posted a second consecutive quarter of <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45236756/rivian-q1-earnings-double-beat-record-gross-profit-delivery-estimates-lowered-on-tariff-concerns" rel="noreferrer noopener">gross profit</a> in the first quarter of 2025, signaling a possible shift toward sustained profitability.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46199580/microsoft-rivian-intel-slash-jobs-in-june-tech-layoff-spree" rel="noreferrer noopener">Microsoft, Rivian, Intel Slash Jobs In June Tech Layoff Spree</a>
A major financial boost came from Volkswagen Group (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWAGY#OTC">VWAGY</a>), which finalized a $1 billion equity investment in Rivian on June 30. Shares were priced at $19.42 apiece, a 33% premium over Rivian&#8217;s 30-day average trading price of $14.56. The investment is part of a broader <a href="https://www.benzinga.com/24/11/41934150/rivian-shares-rise-13-in-pre-market-after-volkswagen-increases-planned-investment-to-58b" target="_blank" rel="noreferrer noopener">$5.8 billion</a> strategic partnership to advance EV software and platform development.
Rivian&#8217;s update comes amid a flurry of strong delivery results across the global EV sector:
<ul class="wp-block-list">
<li>NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) <a href="https://www.benzinga.com/markets/tech/25/07/46191725/nios-june-sales-surge-as-trump-casts-doubt-on-ev-future" target="_blank" rel="noreferrer noopener">reported</a> 72,056 vehicles delivered in Q2 2025, reflecting 25.6% year-over-year growth fueled by its NIO, ONVO, and FIREFLY brands.</li>
<li>XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) <a href="https://www.benzinga.com/markets/tech/25/07/46189960/tesla-rival-xpeng-records-224-surge-in-june-deliveries-crosses-2024-sales-mark-in-6-months" target="_blank" rel="noreferrer noopener">posted</a> a 224% year-over-year surge in June deliveries, with 197,189 units delivered in the first half of 2025. Already surpassing its full-year 2024 totals, this highlights a sharp acceleration in market traction.</li>
<li>Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) <a href="https://www.benzinga.com/markets/tech/25/07/46190208/li-autos-strong-q2-deliveries-mask-junes-steep-decline" target="_blank" rel="noreferrer noopener">reported</a> a 24.1% year-over-year decline in June deliveries, totaling 36,279 vehicles, pointing to mounting pressure amid shifting consumer dynamics and stronger competition.</li>
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46221375/tesla-stock-jumps-on-strong-q2-deliveries" target="_blank" rel="noreferrer noopener">reported</a> 384,122 global deliveries in Q2 2025, including 373,728 Model 3/Y units, alongside 9.6 GWh in energy storage deployment, signaling steady growth in both automotive and energy segments.</li>
</ul>
Meanwhile, Tesla CEO Elon Musk&#8217;s threat to form a <a target="_blank" href="https://www.benzinga.com/news/politics/25/07/46216023/after-trump-warns-elon-musk-to-close-up-shop-china-rallies-behind-worlds-richest-man-theres-no-need-to-keep-putting-up-with-it" rel="noreferrer noopener">new political party</a> in response to President Donald Trump&#8217;s proposed spending bill sparked viral support on the Chinese social media platform Weibo, where users praised his anti-establishment stance. The unexpected international backing highlights Musk&#8217;s growing political influence beyond the U.S. as <a target="_blank" href="https://www.benzinga.com/markets/equities/25/07/46187311/trump-says-elon-musk-would-close-up-shop-and-head-back-home-to-south-africa-without-subsidies-no-more-rocket-launches-satellites-or-electric-car" rel="noreferrer noopener">tensions </a>rise over federal spending and EV-related subsidies.
Rivian plans to release its full second-quarter financial results on August 6, 2025, after the market closes.
Related ETFs include Global X Autonomous &amp; Electric Vehicles ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRIV#NASDAQ">DRIV</a>) and iShares Self-Driving EV and Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDRV#NYSE">IDRV</a>).
Price Action: RIVN shares are trading lower by 3.38% to $13.02 at Wednesday&#8217;s last check.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46217895/scott-bessent-says-senators-not-threatened-by-elon-musks-words-bill-advancing-under-trumps-leadership-more-than-anybodys-checkbook" target="_blank" rel="noreferrer noopener">Scott Bessent Says Senators Not &#8216;Threatened&#8217; By Elon Musk&#8217;s Words, Bill Advancing Under Trump&#8217;s Leadership &#8216;More Than Anybody&#8217;s Checkbook&#8217;</a></li>
</ul>
Photo via Shutterstock

Guidance

DRIV

IDRV

RIVN

TSLA

VWAGY

XPEV

Rivian's Production Dips For Next-Gen Models, Volkswagen Infusion Boosts Outlook

Politics

Reuters Cites Constellation Brands CFO At Conf. Call, Saying Going Forward Impact Of Incremental Tariff That Went Into Effect In June To Be About $20M

Morgan Stanley analyst Keith Weiss maintains ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Equal-Weight and raises the price target from $950 to $1040.

Comments

(AGS) Opzioni

(NYSE:AGS) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO